FNY Investment Advisers’s BioTelemetry, Inc. BEAT Stock Holding History

FNY Investment Advisers’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-15,000	Closed	-$1.08M	–	1159
2020 Q4	$1.08M	Buy	+15,000	New	+$785K	0.29%	85
2019 Q1	–	Sell	-183	Closed	-$10K	–	1111
2018 Q4	$10K	Buy	+183	New	+$11K	﹤0.01%	469

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

FNY Investment Advisers's BEAT Position: Q1 2021 in Review

FNY Investment Advisers sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 15,000 shares — an estimated $1.08M sold.

FNY Investment Advisers first reported a position in BEAT in Q4 2018 and held it in 2 quarters. The position peaked at $1.08M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

FNY Investment Advisers reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
FNY Investment Advisers sold 15,000 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.08M.
FNY Investment Advisers first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 2 quarters.
FNY Investment Advisers's BioTelemetry, Inc. position peaked at $1.08M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on FNY Investment Advisers's 13F filing for Q1 2021, filed 12 Apr 2021.